Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Codeine/Guaifenesin ER vs IR
NCT02157649Phase 1Completed
- Sponsor
- Nexgen Pharma
- Start
- Jun 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of codeine and guaifenesin in cough (3 arms), sponsored by Nexgen Pharma. Primary endpoint: Serum Levels of Codeine and Guaifenesin at 24 hours. Started Jun 2014; status: completed.
02
Drugs
codeineguaifenesin
03
Conditions
cough
Beyond the preview
Go deeper on NCT02157649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02157649.